Details for New Drug Application (NDA): 075028
✉ Email this page to a colleague
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 075028
Tradename: | PENTOXIFYLLINE |
Applicant: | Valeant Pharms |
Ingredient: | pentoxifylline |
Patents: | 0 |
Pharmacology for NDA: 075028
Physiological Effect | Hematologic Activity Alteration |
Medical Subject Heading (MeSH) Categories for 075028
Suppliers and Packaging for NDA: 075028
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075028 | ANDA | NuCare Pharmaceuticals,Inc. | 68071-4532 | 68071-4532-9 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-4532-9) |
PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075028 | ANDA | Oceanside Pharmaceuticals | 68682-101 | 68682-101-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-101-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
Approval Date: | Jul 20, 1998 | TE: | AB | RLD: | No |
Complete Access Available with Subscription